Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Moore

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
The New England Journal of Medicine|October 5, 2017
Obinutuzumab for the First-Line Treatment of Follicular LymphomaRobert Marcus, Andrew Davies, Kiyoshi Ando, et al.
Nature Ecology & Evolution|November 30, 2017
New interventions are needed to save coral reefsKen Anthony, Line K Bay, Robert Costanza, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2021
Assisted gene flow using cryopreserved sperm in critically endangered coralMary Hagedorn, Christopher A Page, Keri L O'Neil, et al.
Journal of Managed Care & Specialty Pharmacy|January 7, 2015
Utilizing data consortia to monitor safety and effectiveness of biosimilars and their innovator products, Mike Baldziki, Jeff Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I TrialMartin Hutchings, Franck Morschhauser, Gloria Iacoboni, et al.
The European Respiratory Journal|July 13, 2023
Oxidised IL-33 drives COPD epithelial pathogenesis <i>via</i> ST2-independent RAGE/EGFR signalling complexSam Strickson, Kirsty F Houslay, Victor A Negri, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
The New England Journal of Medicine|October 5, 2017
Obinutuzumab for the First-Line Treatment of Follicular LymphomaRobert Marcus, Andrew Davies, Kiyoshi Ando, et al.
Nature Ecology & Evolution|November 30, 2017
New interventions are needed to save coral reefsKen Anthony, Line K Bay, Robert Costanza, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2021
Assisted gene flow using cryopreserved sperm in critically endangered coralMary Hagedorn, Christopher A Page, Keri L O'Neil, et al.
Journal of Managed Care & Specialty Pharmacy|January 7, 2015
Utilizing data consortia to monitor safety and effectiveness of biosimilars and their innovator products, Mike Baldziki, Jeff Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I TrialMartin Hutchings, Franck Morschhauser, Gloria Iacoboni, et al.
The European Respiratory Journal|July 13, 2023
Oxidised IL-33 drives COPD epithelial pathogenesis <i>via</i> ST2-independent RAGE/EGFR signalling complexSam Strickson, Kirsty F Houslay, Victor A Negri, et al.
Pageof 7